Stout Jay S

Chief Technology OfficerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Jan 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$51K
Net Open-Market Flow
-$51K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2026Sell(S)2K$26.03$51K198K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001702969-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly: